Loading VIKASECO price...
Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 27 Aug 2026), sales was Rs 119 cr and profit was Rs 2.0 cr.
- Operations used cash in FY26 (-Rs 113 cr) while reported profit was Rs 3.1 cr.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 17 results, the share rose on 5 and fell on 12, and moved by 3% or more on 8.
Q1 FY27: results filed 27 Aug 2026. The share went from its close on 26 Aug 2026 to its close on 28 Aug 2026 +5.56%.
Of every Rs 100 of sales in FY25, Rs 97 went on running costs, Rs 1.3 on depreciation, Rs 1.2 on interest and Rs 1.3 on tax; Rs 4.5 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | -35.8% | 46.1% | - |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 5.4% | 6.2% | 3.2% | - |
| Net marginProfit after everything, per Rs 100 of sales. | 2.4% | 2.6% | 4.5% | - |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | 4.0% | 1.8% | 4.3% | - |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 6.1% | 4.2% | 6.5% | 2.4% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.26x | 0.05x | 0.07x | 0.07x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 2.1x | 2.4x | 5.9x | - |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 513 Cr of assets. Its owners funded 81% of that and borrowings 6%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -113 Cr, spent Rs 4 Cr on plant and equipment, and cash fell by Rs 0 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND Pidilite Industries Limited | 1.50 L cr | 56.9x | 13.9x | 24.2% | 28.5% | 0.01 | 17.4% | +21.3% | 1.01% |
| SRF SRF Limited | 69,362 cr | 30.4x | 4.5x | 14.9% | - | 0.34 | 12.5% | +34.7% | 0.38% |
| FLUOROCHEM Gujarat Fluorochemicals Limited | 46,168 cr | 75.4x | 5.9x | 7.7% | 10.2% | 0.28 | 11.5% | +24.0% | 0.07% |
| NAVINFLUOR Navin Fluorine International Limited | 39,306 cr | 49.8x | 9.9x | 19.9% | 18.7% | 0.31 | 21.7% | +44.1% | 0.17% |
| DEEPAKNTR Deepak Nitrite Limited | 19,676 cr | 25.1x | 3.4x | 13.3% | 10.8% | 0.26 | 9.1% | +36.4% | 0.52% |
| AETHER Aether Industries Limited | 19,529 cr | 82.8x | 8.0x | 9.6% | 12.2% | 0.18 | 19.2% | +52.4% | 0.00% |
| ATUL Atul Limited | 15,762 cr | 20.4x | 2.4x | 11.8% | - | 0.02 | 11.3% | +20.9% | 0.47% |
| AARTIIND Aarti Industries Limited | 15,539 cr | 29.3x | 2.6x | 8.9% | 8.5% | 0.83 | 5.9% | +42.5% | 0.23% |
| FINEORG Fine Organic Industries Limited | 15,328 cr | 35.0x | 5.8x | 16.4% | 20.2% | 0.02 | 17.7% | +18.0% | 0.22% |
| BASF BASF India Limited | 13,174 cr | 20.5x | 3.3x | 16.3% | 13.1% | 0.00 | 4.0% | +24.5% | 0.66% |
| PRIVISCL Privi Speciality Chemicals Limited | 13,109 cr | 49.4x | 9.3x | 23.7% | 25.1% | 0.70 | 12.8% | +19.2% | 0.15% |
| ANURAS Anupam Rasayan India Limited | 12,802 cr | 73.1x | 3.8x | 4.9% | 7.5% | 0.39 | 8.9% | +34.8% | 0.12% |
| SUDEEPPHRM Sudeep Pharma Limited | 11,103 cr | 59.7x | 12.6x | 20.4% | 24.2% | 0.17 | 27.2% | - | 0.00% |
| VINATIORGA Vinati Organics Limited | 10,964 cr | 24.4x | 3.5x | 14.2% | 17.7% | 0.00 | 18.8% | +28.4% | 0.71% |
| JUBLINGREA Jubilant Ingrevia Limited | 9,581 cr | 31.2x | 3.1x | 9.9% | 10.8% | 0.25 | 6.6% | +25.3% | 0.83% |
| ALKYLAMINE Alkyl Amines Chemicals Limited | 8,373 cr | 37.2x | 5.5x | 14.7% | 14.6% | 0.00 | 13.6% | +30.2% | 0.61% |
| CLEAN Clean Science and Technology Limited | 7,835 cr | 33.6x | 5.0x | 14.7% | 19.2% | 0.00 | 23.7% | +10.5% | 0.81% |
| GALAXYSURF Galaxy Surfactants Limited | 7,710 cr | 21.8x | 2.8x | 12.9% | 12.7% | 0.06 | 6.2% | +39.4% | 0.27% |
| NEOGEN Neogen Chemicals Limited | 5,955 cr | 163.7x | 7.3x | 4.4% | 6.8% | 1.63 | 3.8% | +34.0% | 0.04% |
| BALAMINES Balaji Amines Limited | 5,882 cr | 28.7x | 3.0x | 9.8% | 10.2% | 0.06 | 13.8% | +27.2% | 0.61% |
| ACI Archean Chemical Industries Limited | 5,782 cr | 59.4x | 3.0x | 5.0% | 7.8% | 0.24 | 8.6% | +11.9% | 0.64% |
| YASHO Yasho Industries Limited | 4,542 cr | 78.8x | 10.2x | 13.0% | 11.3% | 1.22 | 6.1% | +54.9% | 0.01% |
| FOSECOIND Foseco India Limited | 4,285 cr | 42.6x | 4.0x | 9.4% | - | 0.00 | 13.2% | +47.2% | 0.37% |
| LXCHEM Laxmi Organic Industries Limited | 4,257 cr | 33.9x | 2.1x | 6.3% | 4.4% | 0.27 | 4.0% | +39.8% | 0.33% |
| EPIGRAL Epigral Limited | 3,820 cr | 14.1x | 1.7x | 12.2% | 14.8% | 0.25 | 10.3% | +16.3% | 0.48% |
| VISHNU Vishnu Chemicals Limited | 3,772 cr | 25.1x | 3.5x | 13.9% | 16.2% | 0.49 | 8.8% | +24.9% | 0.05% |
| TATVA Tatva Chintan Pharma Chem Limited | 3,667 cr | 71.3x | 4.7x | 6.6% | 7.6% | 0.15 | 9.2% | +43.0% | 0.06% |
| STYRENIX Styrenix Performance Materials Limited | 3,370 cr | 12.3x | 2.5x | 20.0% | 12.8% | 0.23 | 7.8% | +7.1% | 2.80% |
| CHEMPLASTS Chemplast Sanmar Limited | 3,009 cr | - | 1.7x | -22.3% | -4.1% | 1.11 | -9.2% | +2.3% | 0.00% |
| JUBLCPL Jubilant Agri and Consumer Products Limited | 2,910 cr | 22.7x | 6.3x | 28.2% | 34.9% | 0.06 | 6.6% | +18.4% | 0.00% |
| DDEVPLSTIK Ddev Plastiks Industries Limited | 2,473 cr | 11.6x | 2.4x | 21.1% | 28.9% | 0.05 | 6.7% | +28.6% | 0.94% |
| NOCIL NOCIL Limited | 2,420 cr | 36.7x | 1.4x | 3.7% | 4.1% | 0.00 | 4.8% | +19.9% | 1.40% |
| ROSSARI Rossari Biotech Limited | 2,251 cr | 14.9x | 1.7x | 11.3% | 15.3% | 0.31 | 5.9% | +28.2% | 0.12% |
| OAL Oriental Aromatics Limited | 2,114 cr | 647.5x | 3.2x | 0.8% | 6.2% | 0.61 | 0.5% | +15.2% | 0.08% |
| SHK S H Kelkar and Company Limited | 1,749 cr | 19.6x | 1.3x | 6.5% | 9.6% | 0.62 | 3.6% | +14.1% | 1.58% |
| CAMLINFINE Camlin Fine Sciences Limited | 1,600 cr | 378.6x | 1.5x | 0.1% | 2.9% | 0.67 | 0.0% | +22.7% | 0.00% |
| VIDHIING Vidhi Specialty Food Ingredients Limited | 1,557 cr | 29.2x | 4.8x | 16.2% | 20.9% | 0.18 | 12.1% | +66.4% | 1.45% |
| PAUSHAKLTD Paushak Limited | 1,501 cr | - | 3.1x | - | 8.7% | 0.16 | - | - | 0.40% |
| PLATIND Platinum Industries Limited | 1,242 cr | 24.6x | 2.8x | 10.8% | 14.9% | 0.01 | 11.1% | -5.6% | 0.00% |
| VIKASECO Vikas EcoTech Limited | 137 cr | 49.5x | 0.3x | 0.7% | 2.4% | 0.07 | 0.8% | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 5.4% to 3.2% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
2019 paid Rs 0.05 per share, about Rs 5,051 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.